Tag - avigan

 
 

AVIGAN

Japan Times
JAPAN / Science & Health
Oct 15, 2022
Fujifilm gives up developing Avigan drug for COVID-19 treatment
Avigan, initially developed as a drug for influenza, emerged as a potential treatment for the coronavirus during the early stages of the pandemic.
Japan Times
JAPAN
Mar 11, 2022
Fujifilm to halt enrollment in Avigan trial for COVID-19
The emergence of the omicron variant, which usually causes milder infections, made it tough to determine the drug's effectiveness in preventing severe symptoms, the company said.
Japan Times
JAPAN
Mar 9, 2021
Drugmakers in Japan struggle to keep pace in COVID-19 medicine race
No applications for drugs specifically tailored to COVID-19 have been filed yet, as domestic pharmaceutical companies have not invested heavily enough in biomedicine.
Japan Times
JAPAN / Science & Health
Feb 21, 2021
Fujifilm to restart trial of Avigan to treat COVID-19, report says
Domestic approval of the drug was delayed after a health ministry panel said in December that trial data was inconclusive.
Japan Times
JAPAN / Science & Health
Dec 17, 2020
Japan's review of Avigan as COVID-19 treatment draws blank
The Pharmaceuticals and Medical Devices Agency raised questions about the way tests were performed and the criteria for determining whether symptoms had improved, sources say.
Japan Times
BUSINESS / Companies
Oct 22, 2020
Fujifilm works with Shanghai firm to get Avigan approved in China
Fujifilm Holdings Corp. said on Thursday it has partnered with Shanghai-based Carelink Pharmaceutical Co. to seek approval in China for Avigan to treat COVID-19 and influenza.
Japan Times
BUSINESS / Companies
Oct 16, 2020
Fujifilm seeks approval for Avigan as COVID-19 treatment in Japan
The move comes after a late-stage study showed reduced recovery times for patients with nonsevere symptoms.
Japan Times
JAPAN / Science & Health
Oct 4, 2020
Japan planning quickest-ever approval for anti-viral drug Avigan
According to sources, the government had already mapped out the drug's approval process by the time a Fujifilm unit disclosed data from clinical studies.
JAPAN / Science & Health
Sep 21, 2020
Fujifilm completes delayed Avigan clinical test and looks to government application
Fujifilm Holdings Corp. said Monday it has completed delayed clinical tests of Avigan, a potential treatment for COVID-19, paving the way for the application of sales and production of the antivirus drug.
Japan Times
JAPAN / Science & Health
Aug 17, 2020
Philippines begins nine-month clinical trial on Avigan in COVID-19 study
The Philippines started nine-month clinical trials for Avigan on Monday to study the efficacy of the Japanese anti-flu drug against the disease caused by the new coronavirus.
Japan Times
JAPAN
Aug 13, 2020
Fujifilm to complete delayed Avigan clinical trials in Japan in September
Fujifilm Holdings Corp. said Thursday it expects to complete clinical tests in Japan of the antiviral drug Avigan, a potential candidate treatment drug for COVID-19, in September, already behind schedule after a delay caused by difficulty in securing enough patient data.
Japan Times
JAPAN / Science & Health
Jul 18, 2020
Fujifilm to start another Avigan study in Kuwait following setback in Japan
The trial is to be conducted with India's Dr. Reddy's Laboratories and will involve up to 1,000 people to assess the flu drug's effectiveness against the coronavirus.
Japan Times
JAPAN / Science & Health
Jul 10, 2020
Avigan's effectiveness inconclusive in Japan COVID-19 trial
Promoted heavily by Prime Minister Shinzo Abe, the flu drug did not yield any statistically significant results after administered to 89 patients across Japan.
Japan Times
BUSINESS
Jul 1, 2020
Fujifilm ties up with Indian firm on potential COVID-19 drug Avigan
The drug has yet to be approved by the Japanese government for coronavirus treatment, with clinical testing delayed due to insufficient enrollment.
Japan Times
JAPAN / Science & Health
Jun 24, 2020
Wanted: More COVID-19 patients in Japan ... for clinical trials
Japan has become a victim of its own success as slowing new infections have led to a shortage of patients to enroll in trials for treatments and vaccines.
Japan Times
BUSINESS
Jun 7, 2020
Fujifilm's COVID-19 drug research will drag on into July, source says
The recent fall in the number of confirmed infections has made it difficult to reach the enrollment target of 96 patients.
Japan Times
WORLD / Science & Health
Jun 1, 2020
After fast-tracking Japanese COVID-19 drug, Russia to roll out 'game changer' next week
Russia will start administering its first approved antiviral drug to treat coronavirus patients next week, its state financial backer told Reuters, a move it described as "a game changer" that should speed a return to normal economic life.
Japan Times
JAPAN / Science & Health
May 26, 2020
Japan extends timeline for approving Fujifilm's Avigan drug for COVID-19
Fujifilm shares slumped last week after it was reported that an interim study showed no clear evidence of efficacy for Avigan in COVID-19 cases.
Japan Times
BUSINESS
May 22, 2020
Fujifilm plans to make flu drug Avigan available for 2 million people by March 2021
Fujifilm Holdings Corp. said Friday it is on course to supply the flu drug Avigan for 2 million COVID-19 patients by next March, meeting a target set by the government to ramp up production of the potential but yet unapproved coronavirus treatment.
Japan Times
BUSINESS
May 21, 2020
No pause in coronavirus trial for Avigan, Japan's lead researcher says
The lead researcher in the coronavirus trial for flu drug Avigan says it’s too early to make a call on whether it works and shrugged off negative reports about the interim results, saying patients are still being enrolled.

Longform

Father's Day is said to have come to Japan around 1950, shortly after the establishment of Mother's Day.
The evolving nature of fatherhood in Japan